Concorde Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-504	Closed	-$167K	–	164
2021 Q4	$167K	Buy	504 +35	+7%	+$11.6K	0.1%	162
2021 Q3	$217K	Buy	+469	New	+$217K	0.13%	173